Biohaven Pharmaceutical Holding Co Ltd (BHVN)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 1.66B
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
0
52W High
$ 55.70
52W Low
$ 12.79
Dividend Yield
0.00%
Beta
3.50
Technicals
50-Day MA
14.5812
200-Day MA
28.5097
52 Week High
55.7
52 Week Low
12.79
About BHVN
Biohaven Ltd. discovers, develops, and commercializes therapies for immunology, neuroscience, and oncology worldwide.
Employees
256
Headquarters
New Haven, CT
CEO
Dr. Vladimir Coric M.D.